2014
Pancreatic stone protein – A possible biomarker of multiorgan failure and mortality in children sepsis
ŽUREK, Jiří, Michal KÝR, Martin VAVŘINA a Michal FEDORAZákladní údaje
Originální název
Pancreatic stone protein – A possible biomarker of multiorgan failure and mortality in children sepsis
Autoři
ŽUREK, Jiří (203 Česká republika, garant, domácí), Michal KÝR (203 Česká republika, domácí), Martin VAVŘINA (203 Česká republika, domácí) a Michal FEDORA (203 Česká republika, domácí)
Vydání
Cytokine, Academic Press, 2014, 1043-4666
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30209 Paediatrics
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 2.664
Kód RIV
RIV/00216224:14110/14:00075154
Organizační jednotka
Lékařská fakulta
UT WoS
000333729200003
Klíčová slova anglicky
Children; Mortality; Pancreatic stone protein; Regenerating protein 1 alpha; Sepsis
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 9. 7. 2014 12:17, Ing. Mgr. Věra Pospíšilíková
Anotace
V originále
Pancreatic stone protein is associated with infection. Pancreatic stone protein did not differ between SIRS and sepsis. Pancreatic stone protein levels were higher in patients who died. Pancreatic stone protein (PSP)/regenerating protein 1-alpha (reg) is associated with inflammation, infection, and other disease-related stimuli. The prognostic value of PSP/. reg among critically ill pediatric patients is unknown. The aim of this pilot study was to evaluate PSP/. reg in children with systemic inflammatory response syndrome or sepsis.Prospective observational study, a five day evaluation period in children 0-19. years old with systemic inflammatory response syndrome or septic state. Blood tests to determine levels of PSP/. reg were obtained as long as the patient met the criteria for systemic inflammatory response syndrome or sepsis.PSP/. reg levels did not differ between patients with systemic inflammatory response syndrome and septic condition until organ dysfunction signs were present. PSP/. reg levels were significantly higher in patients with a PELOD score of 12 or higher or in those with MODS. Patients who died tended to have higher PSP/. reg levels.